Trial Profile
Florbetapir PET amyloid imaging for cognitive decline in the oldest-old patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2020
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Cognition disorders; Dementia
- Focus Diagnostic use
- Acronyms The 90+ study
- 31 Jul 2020 Results presented at the Alzheimer's Association International Conference 2020
- 26 May 2015 New trial record